Prednisolone in the form of its hemisuccinate was given intravenously in two different doses (1200 mg and 75 mg). Plasma levels of the ester and prednisolone were measured and pharmacokinetic parameters were calculated. The results indicate a dose-dependency in the pharmacokinetics of both hemisucci
Comparative Pharmacokinetics of Methylprednisolone Phosphate and Hemisuccinate in High Doses
✍ Scribed by Helmut Möllmann; Peter Rohdewald; Jürgen Barth; Carsten Möllmann; Matthi Verho; Hartmut Derendorf
- Book ID
- 114421021
- Publisher
- Springer US
- Year
- 1988
- Tongue
- English
- Weight
- 691 KB
- Volume
- 05
- Category
- Article
- ISSN
- 0724-8741
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The pharmacokinetics of methylprednisolone and methylprednisolone phosphate were investigated after intravenous administration of methylprednisolone phosphate to six healthy subjects at seven different doses between 16 and 1000 mg. Plasma, urine, and saliva were analyzed for methylprednisolone and m
A commercially available 1.0 g intravenous (i.v.) dosage formulation of methylprednisolone, as the sodium hemisuccinate salt (Solu Medrol, Upjohn) was administered both parenterally and orally (pulse steroid therapy) on separate occasions, to eight elderly (mean 65 y) patients with active rheumatoid
The absolute and relative bioavailability of two methylprednisolone formulations (capsules and suspension) was determined along with its pharmacokinetics in -four arthritic female patients, following an unconventional high-dose pulse of 1 g. Plasma concentrations of the drug were measured by a sensi